We are live on
!
Find out more
2L
22NW LP Portfolio holdings
AUM
$105M
1-Year Est. Return
38.33%
This Fund
S&P 500
This Quarter
Est. Return
+23.73%
1 Year Est. Return
+38.33%
3 Year Est. Return
+138.09%
5 Year Est. Return
+232.99%
10 Year Est. Return
–
AUM
$154M
AUM Growth
+$13.2M
(+9.4%)
Cap. Flow
+$168K
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
92.57%
Holding
15
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lantheus
LNTH
|
+$2.91M |
| 2 |
ANEB
Anebulo Pharmaceuticals
ANEB
|
+$706K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Barrett Business Services
BBSI
|
+$3.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 48.82% |
| 2 | Healthcare | 26.17% |
| 3 | Materials | 13.3% |
| 4 | Consumer Discretionary | 4.57% |
| 5 | Consumer Staples | 3.9% |
Similar funds
ICVCFVA
CSW
IAP
VA
JRSI
SFG
TPW
ACM
22NW LP's Q4 2023 Portfolio in Review
As of Q4 2023, 22NW LP held 15 positions worth $154M, up 9.4% from $140M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
22NW LP's Q4 2023 filing shows 1 new, 1 increased, 1 reduced and 1 closed positions. Its largest new stake was Lantheus: 43,000 shares worth $2.67M. The largest sale was Barrett Business Services, an estimated $3.45M.
By sector, the portfolio is most concentrated in Industrials at 49% of assets, up from 47% a quarter earlier, followed by Healthcare and Materials.
- 22NW LP's largest Q4 2023 buy was Lantheus: 43,000 shares worth $2.67M.
- 22NW LP added most to Anebulo Pharmaceuticals in Q4 2023, an estimated $706K increase.
- 22NW LP's biggest Q4 2023 reduction was Barrett Business Services, cutting an estimated $3.45M.
- 22NW LP's ten largest holdings make up 93% of its $154M portfolio in Q4 2023.
- 22NW LP opened 1 new position and closed 1 in Q4 2023.
- 22NW LP's portfolio value rose 9.4% quarter-over-quarter to $154M.
Based on 22NW LP's 13F filing for Q4 2023, filed 14 Feb 2024.